Differentiation Of Immunocytes Using Pluripotent Stem Cells

• US 20200131476A1
• Filed: 10/12/2018
• Published: 04/30/2020
• Est. Priority Date: 12/11/2017
• Status: Abandoned Application

• Current Assignee: Korea Center For Disease Control and Prevention
• Original Assignee: Korea Center For Disease Control and Prevention
• Inventors: Kim, Jung Hyun, Han, Hyo Won, Seo, Hyang Hee, Han, Hyeong Jun
• Application Number:
  US16/624,129
• Publication Number:
  US 20200131476A1
• Time in Patent Office: Days
• CPC Class Codes: A61K 39/4614 Monocytes; Macrophages
• CPC Class Codes: A61K 39/4622 Antigen presenting cells
• CPC Class Codes: A61K 39/464817 Mycobacterium, e.g. Mycobacterium tuberculosis
• CPC Class Codes: C12N 2500/36 Lipids
• CPC Class Codes: C12N 2501/115 Basic fibroblast growth factor (bFGF, FGF-2)
• CPC Class Codes: C12N 2501/125 Stem cell factor [SCF], c-kit ligand [KL]
• CPC Class Codes: C12N 2501/145 Thrombopoietin [TPO]
• CPC Class Codes: C12N 2501/15 Transforming growth factor beta (TGF-β)
• CPC Class Codes: C12N 2501/155 Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
• CPC Class Codes: C12N 2501/165 Vascular endothelial growth factor [VEGF]
• CPC Class Codes: C12N 2501/22 Colony stimulating factors (G-CSF, GM-CSF)
• CPC Class Codes: C12N 2501/2303 Interleukin-3 (IL-3)
• CPC Class Codes: C12N 2501/2306 Interleukin-6 (IL-6)
• CPC Class Codes: C12N 2501/26 Flt-3 ligand (CD135L, flk-2 ligand)
• CPC Class Codes: C12N 2501/999 Small molecules not provided for elsewhere
• CPC Class Codes: C12N 2506/02 from embryonic cells
• CPC Class Codes: C12N 2506/03 from non-embryonic pluripotent stem cells
• CPC Class Codes: C12N 2506/45 from artificially induced pluripotent stem cells
• CPC Class Codes: C12N 5/0645 Macrophages, e.g. Kuepfer cells in the liver; Monocytes
• CPC Class Codes: C12N 5/0647 Haematopoietic stem cells; Uncommitted or multipotent progenitors

Abstract

The present invention relates to a method for inducing the differentiation of hematopoietic stem cells or macrophages by using pluripotent stem cells, and a composition for inducing the differentiation. Specifically, the present invention relates to a composition for inducing the differentiation of hematopoietic stem cells comprising bone morphogenetic protein 4 (BMP4) in pluripotent stem cells, or a composition for inducing the differentiation of macrophages comprising BMP4 and a macrophage-colony stimulating factor (M-CSF), and a method for inducing the differentiation by using the compositions. The method for inducing the differentiation of the present invention is advantageous in that a differentiation method thereof is simple since only a few types of cytokine are used, and compared to conventional methods for inducing the differentiation, the efficiency of differentiation is improved tens of times or more and the yield of differentiated cells is high.

Claims

1. A method for inducing the differentiation of hematopoietic stem cells, characterized in that the method comprisesa step of culturing pluripotent stem cells in a medium for inducing the differentiation of hematopoietic stem cells that comprises BMP4;

2) a step of culturing the pluripotent stem cells by treating the pluripotent stem cells with VEGF and SCF; and

3) a step of treating the pluripotent stem cells with TPO, IL-6, IL-3, and Flt3.

2. The method for inducing the differentiation of hematopoietic stem cells according to claim 1, characterized in that step 1) comprises further treating with CDDO methyl ester.

3. The method for inducing the differentiation of hematopoietic stem cells according to claim 1, characterized in that the medium in step 1) does not further comprise any one or more of Activin A, bFGF, and TGFb.

4. The method for inducing the differentiation of hematopoietic stem cells according to claim 1, characterized in that BMP4 in step 1) is comprised at a concentration of 20 to 100 ng/ml.

5. The method for inducing the differentiation of hematopoietic stem cells according to claim 1, characterized in that step 1) comprises treating with BMP4 at a low concentration followed by treating with BMP4 at a high concentration once again.

6. The method for inducing the differentiation of hematopoietic stem cells according to claim 1, characterized in that the medium for inducing the differentiation of hematopoietic stem cells is APEL (albumin polyvinylalcohol essential lipids).

9. Hematopoietic stem cells differentiated from the pluripotent stem cells, characterized in that the differentiation is induced by the method for inducing the differentiation according to claim 1.

7. A method for inducing the differentiation of macrophages, comprisinga step of culturing pluripotent stem cells in a medium for inducing the differentiation of hematopoietic stem cells that comprises BMP4;

2) a step of culturing the pluripotent stem cells by treating the pluripotent stem cells with VEGF and SCF;

3) a step of inducing the differentiation of hematopoietic stem cells by treating the pluripotent stem cells with TPO, IL-6, IL-3, and Flt3; and

4) a step of culturing the differentiated hematopoietic stem cells by adding the differentiated hematopoietic stem cells to a medium for inducing the differentiation of macrophages that comprises M-CSF.

8. The method for inducing the differentiation of macrophages according to claim 7, characterized in that the cell density is maintained at 1×

10⁵ cells/cm² or more when culturing macrophages in step

     4).

10. Macrophages differentiated from the pluripotent stem cells, characterized in that the differentiation is induced by the method for inducing the differentiation according to claim 7.

11. A composition for inducing the differentiation of hematopoietic stem cells or macrophages derived from pluripotent stem cells, comprising one or more selected from the group consisting of bone morphogenetic protein 4 (BMP4), vascular endothelial growth factor (VEGF), stem cell factor (SCF), platelet growth factor (thrombopoietin, TPO), interleukin-6 (IL-6), interleukin-3 (IL-3), CDDO methyl ester, FMS-like tyrosine kinase (FMS-like tyrosine kinase 3, Flt3) and macrophage-colony stimulating factor (M-CSF).

12. The composition according to claim 11, for inducing the differentiation of macrophages derived from pluripotent stem cells, comprising one or more selected from the group consisting of bone morphogenetic protein 4 (BMP4), vascular endothelial growth factor (VEGF), stem cell factor (SCF), platelet growth factor (thrombopoietin, TPO), interleukin-6 (IL-6), interleukin-3 (IL-3), FMS-like tyrosine kinase (FMS-like tyrosine kinase 3, Flt3), and macrophage-colony stimulating factor (M-CSF).

13. The composition according to claim 11, for inducing the differentiation of hematopoietic stem cells derived from pluripotent stem cells, comprising one or more selected from the group consisting of bone morphogenetic protein 4 (BMP4), vascular endothelial growth factor (VEGF), stem cell factor (SCF), platelet growth factor (thrombopoietin, TPO), interleukin-6 (IL-6), interleukin-3 (IL-3), CDDO methyl ester, and FMS-like tyrosine kinase (FMS-like tyrosine kinase 3, Flt3).